The United States Food and Drug Administration
Abstrak
The Food and Drug Administration ("FDA") recently updated its position on Bisphenol A ("BPA") citing certain studies as the basis for "some concern" about the potential effects of BPA on the brain, behavior, and prostate glands of fetuses, infants and young children. Prior to that announcement, the FDA had not publicly questioned the safety of BPA. Although BPA's permitted uses under FDA regulations have not changed, the FDA's subtle change in position will likely encourage more potential plaintiffs to join the growing litigation against manufacturers of BPA containing products. Manufacturers of any product that has ever contained BPA should be aware of the FDA's evolving position, as well as the status of BPA litigation to ensure they are prepared to defend any claims and to comply with the law.
Akses Cepat
- Tahun Terbit
- 2019
- Bahasa
- en
- Total Sitasi
- 672×
- Sumber Database
- Semantic Scholar
- DOI
- 10.1142/9789813278851_0008
- Akses
- Open Access ✓